Development, validation, and evaluation of a deep learning model to screen cyclin-dependent kinase 12 inhibitors in cancers-Reference-Cited by-同舟云学术

Development, validation, and evaluation of a deep learning model to screen cyclin-dependent kinase 12 inhibitors in cancers

Published:2023-03 Issue: Volume:250 Page:115199
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Wen Tingyu,Wang Jun,Lu Ruiqiang,Tan Shuoyan,Li Pengyong,Yao Xiaojun,Liu Huanxiang,Yi Zongbi,Li Lixi,Liu Shuning,Gao Peng,Qian Haili,Xie Guotong,Ma Fei^ORCID

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference39 articles.

1. Expression, purification, and identification of associated proteins of the full-length hcdk12/cyclink complex;Bartkowiak;J. Biol. Chem.,2015

2. Nadav Rappoport, and Michal Linial. Proteinbert: a universal deep-learning model of protein sequence and function;Brandes;Bioinformatics,2022

3. Language Models Are Few-Shot Learners;Brown,2020

4. Molecular fingerprint similarity search in virtual screening;Cereto-Massagué;Methods,2015

5. Advancing drug discovery via artificial intelligence;Stephen Chan;Trends Pharmacol. Sci.,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Artificial intelligence for small molecule anticancer drug discovery;Expert Opinion on Drug Discovery;2024-06-18

2. Artificial intelligence-based protein structure prediction and systems biology-guided smart drug screening;Biochemical and Molecular Pharmacology in Drug Discovery;2024

3. LaSOM335, active against bladder cancer cells, interferes withLet‐60(hRas) and reducesCD73 expression/activity;Chemical Biology & Drug Design;2023-06-05